The global companion animal diagnostics market size was estimated at USD 7.06 billion in 2025 and is projected to reach USD 14.41 billion by 2033, growing at a CAGR of 9.27% from 2026 to 2033. The market is experiencing growth driven by rising pet ownership, increasing spending on advanced veterinary care, and growing awareness of early disease detection. Increasing humanization of pets, rising demand for preventive healthcare services, and growing adoption of advanced diagnostic technologies in veterinary medicine are also contributing significantly to market growth worldwide.
Companion animal diagnostics involve a wide range of diagnostic tests and technologies used to detect diseases, monitor health conditions, and support treatment planning for pets such as dogs and cats. Veterinary clinics, hospitals, and diagnostic laboratories increasingly rely on advanced diagnostic solutions including clinical chemistry analyzers, imaging systems, molecular diagnostics, and immunodiagnostic tests to improve disease detection and treatment outcomes. Growing awareness regarding animal health management and increasing focus on preventive veterinary care are further supporting the expansion of the companion animal diagnostics market globally.
Key Market Trends & Insights
- North America companion animal diagnostics market held the largest revenue share of 37.91% in 2025. The region’s dominance is supported by high pet ownership rates, advanced veterinary healthcare infrastructure, increasing expenditure on pet care, and strong adoption of advanced diagnostic technologies. Pet owners across North America are increasingly prioritizing routine veterinary check-ups and early disease detection to improve the health and longevity of companion animals. Rising availability of specialized veterinary services and increasing investments in animal healthcare are also contributing significantly to regional market growth.
- The U.S. companion animal diagnostics market is dominated with the largest revenue share in 2025. The country continues to witness strong demand for advanced veterinary diagnostic services due to increasing pet adoption, rising awareness regarding pet wellness, and growing expenditure on companion animal healthcare. Veterinary clinics and hospitals in the U.S. are increasingly integrating advanced diagnostic systems to improve disease diagnosis and treatment efficiency. In addition, increasing demand for preventive care and early disease screening among pet owners is supporting long-term market expansion.
- By product, the consumables, reagents & kits segment held the largest share of 64.96% in the market in 2025. Consumables, reagents, and diagnostic kits are extensively utilized in veterinary diagnostic procedures due to their essential role in disease testing, sample analysis, and clinical examinations. Veterinary healthcare providers increasingly rely on these products for routine blood tests, infectious disease detection, and biochemical analysis. Rising frequency of veterinary diagnostic testing and increasing demand for accurate and rapid diagnostic solutions are contributing significantly to the dominance of this segment.
- By animal type, the dog segment is the largest in the market in 2025. Dogs account for a significant share of companion animal diagnostic procedures due to high ownership rates and increasing awareness regarding canine healthcare. Rising incidences of chronic diseases, infectious conditions, and age-related disorders among dogs are driving demand for advanced diagnostic testing and preventive veterinary care. Pet owners are increasingly seeking regular health monitoring and early disease detection services to improve the overall well-being of companion animals.
- Based on the testing category, the clinical chemistry segment held the largest market share in 2025. Clinical chemistry diagnostics are widely utilized in veterinary medicine to assess organ function, monitor metabolic conditions, and detect various diseases in companion animals. Veterinary professionals increasingly depend on clinical chemistry analyzers for routine diagnostic evaluations and health monitoring. Advancements in veterinary laboratory technologies and growing adoption of automated diagnostic systems are further supporting the expansion of the clinical chemistry segment globally.
Looking for more specific insights? Customize this report to suite your business needs
Key Companies & Market Share Insights
The companion animal diagnostics market is highly competitive, with key players such as IDEXX Laboratories, Zoetis Inc., and Thermo Fisher Scientific holding significant market shares. These companies are actively engaging in strategic moves such as mergers, acquisitions, partnerships, and geographic expansions to reinforce their competitive positions. The presence of emerging regional players and increased investments in R&D are intensifying market competition and shaping the market dynamics.
Key Companion Animal Diagnostics Companies:
- IDEXX Laboratories, Inc.
- Zoetis
- Antech Diagnostics, Inc. (Mars Inc.)
- Agrolabo S.p.A.
- Embark Veterinary, Inc.
- Esaote SPA
- Thermo Fisher Scientific, Inc.
- Innovative Diagnostics SAS
- Virbac
- FUJIFILM Corporation
Grand View Research offers
- Focused market intelligence reports on specific geographies or high-growth segments.
- Extended forecast timelines for long-term planning.
- Competitor Benchmarking and Supply Chain Analysis
- Inclusion of regulatory and policy assessments.
- Inclusion of custom data models, KPIs, or applications unique to your business
- Specific high-impact Data Decks and Tables to support effective decision making
- And much more…
Looking for a report customized to your requirements? Explore our Custom Research Offering